Visceral Leishmaniasis in an Immunocompetent Patient : A Case Report
Leishmaniasis is a parasitic disease transmitted by the bite of female sandflies that occurs in tropical and subtropical climate regions. Visceral leishmaniasis is the most serious manifestation of the disease, leading to a 95% mortality rate after two years of infection if untreated. Visceral leishmaniasis is frequently associated with immunocompromised states, with the human immunodeficiency virus being the most prevalent. Most cases of visceral leishmaniasis are caused by the species Leishmania donovani and Leishmania infantum, the latter being the endemic species in the Mediterranean basin. In Portugal, the number of reported cases of visceral leishmaniasis has decreased in the last few years, with 15 cases reported between 2017 and 2021. The authors present a case of visceral leishmaniasis in an immunocompetent patient who manifested the classic pentad: fever, weight loss, hepatosplenomegaly, pancytopenia and hypergammaglobulinemia. The diagnosis was made by the observation of amastigotes of the Leishmania infantum species in the bone marrow aspirate examination, and the patient was successfully treated with liposomal amphotericin B.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:36 |
|---|---|
| Enthalten in: |
Acta medica portuguesa - 36(2023), 12 vom: 04. Dez., Seite 835-840 |
| Sprache: |
Portugiesisch |
|---|
| Weiterer Titel: |
Leishmaniose Visceral em Doente Imunocompetente: Relato de um Caso |
|---|
| Beteiligte Personen: |
Rodrigues Monteiro, Miguel [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Amphotericin B/therapeutic use |
|---|
| Anmerkungen: |
Date Completed 06.12.2023 Date Revised 06.12.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.20344/amp.19010 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM358520231 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM358520231 | ||
| 003 | DE-627 | ||
| 005 | 20231226074926.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||por c | ||
| 024 | 7 | |a 10.20344/amp.19010 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1195.xml |
| 035 | |a (DE-627)NLM358520231 | ||
| 035 | |a (NLM)37350643 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a por | ||
| 100 | 1 | |a Rodrigues Monteiro, Miguel |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Visceral Leishmaniasis in an Immunocompetent Patient |b A Case Report |
| 246 | 3 | 3 | |a Leishmaniose Visceral em Doente Imunocompetente: Relato de um Caso |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 06.12.2023 | ||
| 500 | |a Date Revised 06.12.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Leishmaniasis is a parasitic disease transmitted by the bite of female sandflies that occurs in tropical and subtropical climate regions. Visceral leishmaniasis is the most serious manifestation of the disease, leading to a 95% mortality rate after two years of infection if untreated. Visceral leishmaniasis is frequently associated with immunocompromised states, with the human immunodeficiency virus being the most prevalent. Most cases of visceral leishmaniasis are caused by the species Leishmania donovani and Leishmania infantum, the latter being the endemic species in the Mediterranean basin. In Portugal, the number of reported cases of visceral leishmaniasis has decreased in the last few years, with 15 cases reported between 2017 and 2021. The authors present a case of visceral leishmaniasis in an immunocompetent patient who manifested the classic pentad: fever, weight loss, hepatosplenomegaly, pancytopenia and hypergammaglobulinemia. The diagnosis was made by the observation of amastigotes of the Leishmania infantum species in the bone marrow aspirate examination, and the patient was successfully treated with liposomal amphotericin B | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a English Abstract | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Amphotericin B/therapeutic use | |
| 650 | 4 | |a Immunocompetence | |
| 650 | 4 | |a Leishmania infantum | |
| 650 | 4 | |a Leishmaniasis | |
| 650 | 4 | |a Liposomal amphotericin B | |
| 650 | 4 | |a Visceral | |
| 700 | 1 | |a Serra, João Tiago |e verfasserin |4 aut | |
| 700 | 1 | |a Gomes, Filipa |e verfasserin |4 aut | |
| 700 | 1 | |a Tinoco, Joaquim |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Acta medica portuguesa |d 1993 |g 36(2023), 12 vom: 04. Dez., Seite 835-840 |w (DE-627)NLM000463329 |x 1646-0758 |7 nnns |
| 773 | 1 | 8 | |g volume:36 |g year:2023 |g number:12 |g day:04 |g month:12 |g pages:835-840 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.20344/amp.19010 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 36 |j 2023 |e 12 |b 04 |c 12 |h 835-840 | ||